FR2801508B1 - Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee - Google Patents
Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrheeInfo
- Publication number
- FR2801508B1 FR2801508B1 FR9914998A FR9914998A FR2801508B1 FR 2801508 B1 FR2801508 B1 FR 2801508B1 FR 9914998 A FR9914998 A FR 9914998A FR 9914998 A FR9914998 A FR 9914998A FR 2801508 B1 FR2801508 B1 FR 2801508B1
- Authority
- FR
- France
- Prior art keywords
- seborrhea
- treatment
- reductase inhibitors
- hmg coa
- hmg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9914998A FR2801508B1 (fr) | 1999-11-29 | 1999-11-29 | Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee |
PCT/FR2000/003288 WO2001039770A1 (fr) | 1999-11-29 | 2000-11-24 | UTILISATION D'INHIBITEURS D'HMG CoA-REDUCTASE POUR LE TRAITEMENT DE LA SEBORRHEE |
AU21777/01A AU2177701A (en) | 1999-11-29 | 2000-11-24 | Use of hmg-coa reductase inhibitors for treating seborrhea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9914998A FR2801508B1 (fr) | 1999-11-29 | 1999-11-29 | Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2801508A1 FR2801508A1 (fr) | 2001-06-01 |
FR2801508B1 true FR2801508B1 (fr) | 2003-11-14 |
Family
ID=9552650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9914998A Expired - Fee Related FR2801508B1 (fr) | 1999-11-29 | 1999-11-29 | Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2177701A (fr) |
FR (1) | FR2801508B1 (fr) |
WO (1) | WO2001039770A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004026297A1 (fr) * | 2002-09-20 | 2004-04-01 | Kowa Co., Ltd. | Preparation pour usage externe |
FR2868309B1 (fr) * | 2004-04-02 | 2006-05-26 | Oreal | Utilisation cosmetique d'au moins un inhibiteur d'hmg-coa-reductase comme agent destine a prevenir et/ou lutter contre les rides d'expression |
ES2385752T3 (es) | 2006-04-26 | 2012-07-31 | Rosemont Pharmaceuticals Ltd | Composiciones orales líquidas |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5021451A (en) * | 1988-11-14 | 1991-06-04 | Hoffman-La Roche Inc. | Method for inhibiting hyperproliferative diseases |
JPH04193836A (ja) * | 1990-11-26 | 1992-07-13 | Banyu Pharmaceut Co Ltd | 抗高脂血症剤 |
IL110943A (en) * | 1994-09-13 | 1997-02-18 | Univ Ramot | Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders |
EP0738510A3 (fr) * | 1995-04-20 | 2005-12-21 | L'oreal | Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes |
AU1593797A (en) * | 1996-01-23 | 1997-08-20 | Novartis Ag | Use of fluvastatin derivatives in skin disease and topical compositions containing them |
-
1999
- 1999-11-29 FR FR9914998A patent/FR2801508B1/fr not_active Expired - Fee Related
-
2000
- 2000-11-24 AU AU21777/01A patent/AU2177701A/en not_active Abandoned
- 2000-11-24 WO PCT/FR2000/003288 patent/WO2001039770A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2177701A (en) | 2001-06-12 |
FR2801508A1 (fr) | 2001-06-01 |
WO2001039770A1 (fr) | 2001-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR07C0046I2 (fr) | Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b | |
FR12C0077I2 (fr) | Composition pour le traitement des condylomes génitaux | |
MA26790A1 (fr) | Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie | |
NO974821L (no) | Anvendelse av <alfa>1L-antagonister for behandling av urininkontinens | |
MA26822A1 (fr) | Composes pour le traitement d'une ischemie. | |
FR2785521B1 (fr) | Dispositif de suspension pour le traitement de prolapsus et d'incontinences urinaires | |
CH1143977H1 (fr) | 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite | |
DE60044625D1 (de) | Système d'assistance de conduire pour vehicules | |
MA26914A1 (fr) | Derives bicycliques substitues pour le traitement d'une croissance cellulaire anormale | |
DZ3014A1 (fr) | Médicaments pour le traitement de l'hypertension. | |
FR2840804B1 (fr) | Systeme pour le traitement de l'obesite et implant pour un tel systeme | |
FR13C0044I2 (fr) | Utilisation de dihydroimidazolones pour le traitement de l'epilepsie canine | |
MA24332A1 (fr) | Utilisation de 1-hydroxy-2- pyridones pour le traitement d'infections de la peau | |
FR2741262B1 (fr) | Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene | |
FR2746658B1 (fr) | Valve de drainage implantable pour le traitement de l'hydrocephalie | |
FR2771727B1 (fr) | Defluoruration d'eaux usees | |
FR2758465B1 (fr) | Composition pour le traitement de l'amiante | |
FR2810547B1 (fr) | Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif | |
FR2740792B1 (fr) | Systeme d'evacuation pour bac de sanitaires | |
FR2801508B1 (fr) | Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee | |
DZ1988A1 (fr) | Thérapie de combinaison pour le traitement de l'hiv. | |
FR2737110B1 (fr) | Utilisation d'acides monocarboxyliques pour le traitement des matieres keratiniques | |
FR2751637B1 (fr) | Cellule d'electrocoagulation pour le traitement d'effluents | |
FR2818150B1 (fr) | Composition pour le traitement d'objets destines a etre desinfectes | |
FR2759290B1 (fr) | Minalcipran pour le traitement de l'incontinence urinaire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20080930 |